Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain
Arthritis Care & Research · 2025
DOI: 10.1002/acr.25569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Luis G Alcala-Gonzalez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Digestive System Research Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Avoidant Restrictive Food Intake Disorder, Feeding and Eating Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Objective
Patients with systemic sclerosis (SSc) may restrict food intake to manage their symptoms (particularly gastrointestinal [GI]). Whether some patients may develop nutritional and/or quality‐of‐life impairments indicative of an eating disorder, avoidant or restrictive food intake disorder (ARFID), is unknown. We aimed to (1) identify the prevalence and characteristics of ARFID symptoms in patients with SSc and (2) explore the relationship among ARFID symptoms, GI symptom burden, and health‐related quality of life.
Methods
In a cross‐sectional internet survey nationwide in Spain, patients with SSc completed the Spanish Nine‐Item ARFID Screen and assessments of gastrointestinal symptom burden (University of California Los Angeles Scleroderma Clinical Trial Consortium GI tract 2.0 [UCLA SCTC GIT 2.0]) and health‐related quality of life (12‐item Short Form Survey [SF‐12]).
Results
Of 200 patients with SSc, 99 patients (49.5%) screened positive for ARFID. Just over half of those who screened positive for ARFID (n = 53) screened positive based on having a fear of aversive consequences around eating (eg, GI discomfort). A positive ARFID screen was associated with a greater frequency of self‐reported enteral nutrition, weight loss, and self‐initiated (vs provider‐monitored) diet restrictions. ARFID symptoms were moderately associated with worse GI symptom severity by UCLA GIT 2.0 total score (r = 0.408, P < 0.001) but not for the reflux subscale (r = 0.058, P = 0.420) and constipation subscale (r = 0.090, P = 0.209) and with worse health‐related quality of life in all domains and both the physical and mental components of the SF‐12 (all P < 0.05).
Conclusion
ARFID symptoms were relatively common in patients with SSc. Future research is needed to identify when a positive screen for ARFID reflects an adaptive response to disease or pathologic restriction indicative of ARFID warranting behavioral treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Digestive System Research Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.
- Massachusetts General Hospital and Harvard Medical School, Boston.
- Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
- Digestive System Research Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas, and Department of Medicine, Universitat Aut…
- Division of Musculoskeletal and Dermatological Sciences, The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK, and Northern Care Alliance NHS Foundation Trust, Salford Care Organisa…
- University of Texas Health Science Center at Houston.
ORCID-Profile: Luis G Alcala-Gonzalez, Alfredo Guillen-Del-Castillo, Carolina Malagelada, Michael Hughes, Zsuzsanna H McMahan, Carmen P Simeón-Aznar
Förderung
- NIDDK NIH HHS
- NIAMS NIH HHS
- NIH HHS
- Asociación Española de Gastroenterologia
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Alcala-Gonzalez, L. G., Burton-Murray, H., Atkins, M., Guillen-Del-Castillo, A., Malagelada, C., Hughes, M., McMahan, Z. H., & Simeón-Aznar, C. P. (2025). Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain. Arthritis Care & Research. https://doi.org/10.1002/acr.25569
Vancouver
Alcala-Gonzalez LG, Burton-Murray H, Atkins M, Guillen-Del-Castillo A, Malagelada C, Hughes M, et al. Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain. Arthritis Care & Research. 2025. doi:10.1002/acr.25569
BibTeX
@article{AlcalaGonzalez2025,
author = {Alcala-Gonzalez, Luis G and Burton-Murray, Helen and Atkins, Micaela and Guillen-Del-Castillo, Alfredo and Malagelada, Carolina and Hughes, Michael and McMahan, Zsuzsanna H and Simeón-Aznar, Carmen P},
title = {Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain},
journal = {Arthritis Care & Research},
year = {2025},
doi = {10.1002/acr.25569}
}
EUVIMED